EVERSPIN TECHNOLOGIES INC (MRAM) Stock Fundamental Analysis
NASDAQ:MRAM - Nasdaq - US30041T1043 - Common Stock - Currency: USD
Taking everything into account, MRAM scores 5 out of 10 in our fundamental rating. MRAM was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While MRAM has a great health rating, there are worries on its profitability. MRAM has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year MRAM was profitable.
MRAM had a positive operating cash flow in the past year.
MRAM had positive earnings in 4 of the past 5 years.
Of the past 5 years MRAM 4 years had a positive operating cash flow.
1.2 Ratios
MRAM has a Return On Assets (-0.23%) which is comparable to the rest of the industry.
MRAM has a Return On Equity of -0.29%. This is comparable to the rest of the industry: MRAM outperforms 42.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.23% | ||
| ROE | -0.29% | ||
| ROIC | N/A |
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of MRAM has declined.
MRAM's Gross Margin of 50.33% is in line compared to the rest of the industry. MRAM outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of MRAM has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MRAM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
2. Health
2.1 Basic Checks
MRAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MRAM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MRAM has more shares outstanding
There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 3.95 indicates that MRAM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.95, MRAM is in line with its industry, outperforming 54.55% of the companies in the same industry.
There is no outstanding debt for MRAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.95 |
ROIC/WACCN/A
WACC11.61%
2.3 Liquidity
MRAM has a Current Ratio of 5.31. This indicates that MRAM is financially healthy and has no problem in meeting its short term obligations.
MRAM has a better Current ratio (5.31) than 81.82% of its industry peers.
A Quick Ratio of 4.44 indicates that MRAM has no problem at all paying its short term obligations.
MRAM has a Quick ratio of 4.44. This is in the better half of the industry: MRAM outperforms 78.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.31 | ||
| Quick Ratio | 4.44 |
3. Growth
3.1 Past
MRAM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.73%.
Measured over the past years, MRAM shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.88% on average per year.
The Revenue for MRAM has decreased by -22.49% in the past year. This is quite bad
Measured over the past years, MRAM shows a small growth in Revenue. The Revenue has been growing by 6.09% on average per year.
EPS 1Y (TTM)-46.73%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-71.43%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%-8.95%
3.2 Future
The Earnings Per Share is expected to grow by 95.49% on average over the next years. This is a very strong growth
Based on estimates for the next years, MRAM will show a quite strong growth in Revenue. The Revenue will grow by 10.89% on average per year.
EPS Next Y-46.97%
EPS Next 2Y8.08%
EPS Next 3Y95.49%
EPS Next 5YN/A
Revenue Next Year8.96%
Revenue Next 2Y10.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.07, the valuation of MRAM can be described as rather expensive.
Based on the Price/Earnings ratio, MRAM is valued a bit cheaper than the industry average as 75.45% of the companies are valued more expensively.
MRAM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 17.64, which indicates a rather expensive current valuation of MRAM.
77.27% of the companies in the same industry are more expensive than MRAM, based on the Price/Forward Earnings ratio.
MRAM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.07 | ||
| Fwd PE | 17.64 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRAM indicates a rather cheap valuation: MRAM is cheaper than 80.91% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MRAM's earnings are expected to grow with 95.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.08%
EPS Next 3Y95.49%
5. Dividend
5.1 Amount
MRAM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.74
-0.11 (-1.61%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners64.72%
Inst Owner Change0%
Ins Owners4.8%
Ins Owner Change31.19%
Market Cap151.45M
Analysts82.5
Price Target9.18 (36.2%)
Short Float %3.9%
Short Ratio6.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)649.18%
Min EPS beat(2)91.18%
Max EPS beat(2)1207.19%
EPS beat(4)4
Avg EPS beat(4)779%
Min EPS beat(4)50.98%
Max EPS beat(4)1766.67%
EPS beat(8)8
Avg EPS beat(8)417.98%
EPS beat(12)12
Avg EPS beat(12)619.13%
EPS beat(16)16
Avg EPS beat(16)696.7%
Revenue beat(2)2
Avg Revenue beat(2)3.45%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)0.9%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)3.87%
Revenue beat(8)6
Avg Revenue beat(8)1.43%
Revenue beat(12)10
Avg Revenue beat(12)1.68%
Revenue beat(16)14
Avg Revenue beat(16)3.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.76%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.07 | ||
| Fwd PE | 17.64 | ||
| P/S | 3.08 | ||
| P/FCF | 23 | ||
| P/OCF | 15.4 | ||
| P/B | 2.4 | ||
| P/tB | 2.52 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.28
EY4.15%
EPS(NY)0.38
Fwd EY5.67%
FCF(TTM)0.29
FCFY4.35%
OCF(TTM)0.44
OCFY6.49%
SpS2.19
BVpS2.81
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.23% | ||
| ROE | -0.29% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.33% | ||
| FCFM | 13.41% |
ROA(3y)8.51%
ROA(5y)2.08%
ROE(3y)11.3%
ROE(5y)0.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-41.82%
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.18%
F-Score3
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 148.97% | ||
| Cap/Sales | 6.61% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.31 | ||
| Quick Ratio | 4.44 | ||
| Altman-Z | 3.95 |
F-Score3
WACC11.61%
ROIC/WACCN/A
Cap/Depr(3y)192.66%
Cap/Depr(5y)132.94%
Cap/Sales(3y)4.31%
Cap/Sales(5y)3.11%
Profit Quality(3y)251.99%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.73%
EPS 3Y-4.88%
EPS 5YN/A
EPS Q2Q%-71.43%
EPS Next Y-46.97%
EPS Next 2Y8.08%
EPS Next 3Y95.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y-2.96%
Revenue growth 5Y6.09%
Sales Q2Q%-8.95%
Revenue Next Year8.96%
Revenue Next 2Y10.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-283.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year950%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.42%
FCF growth 3Y-21.44%
FCF growth 5YN/A
OCF growth 1Y-15.68%
OCF growth 3Y-8.8%
OCF growth 5YN/A